KUALA LUMPUR, 18 March 2026 – Sunway Healthcare Group has marked a major milestone with its listing on Bursa Malaysia, as founder Tan Sri Dato’ Seri Dr. Jeffrey Cheah outlined an ambitious vision to scale the group into a world-class healthcare institution.
The listing represents one of Malaysia’s most significant healthcare IPOs in recent years, drawing strong participation from both domestic and international investors. Institutional investors accounted for approximately 60% of the bookbuilding, reflecting robust global confidence in the group’s long-term growth trajectory.
From Single Hospital to Integrated Healthcare Ecosystem
Speaking at the listing ceremony, Jeffrey Cheah highlighted that Sunway Healthcare’s journey began nearly three decades ago with a vision to build a world-class medical centre within Sunway City.
What started as a single private hospital has since evolved into a comprehensive healthcare ecosystem encompassing advanced clinical care, education, and research capabilities. Today, Sunway Medical Centre is widely recognised as one of Malaysia’s leading private hospitals, frequently handling complex cases referred from across the region.
The group’s rise has also been supported by growing international recognition, including improved global rankings and its position as Malaysia’s top private hospital for consecutive years.
Strong Market Debut Reflects Investor Confidence
The IPO’s strong reception underscores investor appetite for Malaysia’s healthcare sector, which continues to benefit from rising demand, medical tourism growth, and structural healthcare spending.
Sunway Healthcare now joins a broader ecosystem of listed Sunway entities, including Sunway Berhad, Sunway REIT, and Sunway Construction Group, collectively contributing more than RM57 billion in market capitalisation to Malaysia’s capital markets.
Governance and Value Creation in Focus
As a newly listed entity, Sunway Healthcare has pledged to uphold high standards of corporate governance, transparency, and accountability, a key factor in sustaining investor trust.
Jeffrey Cheah emphasised that long-term success will depend on strong core values and a clear commitment to ethical and responsible business practices, particularly in a sector as critical as healthcare.
Expansion Plans and Capacity Growth
Looking ahead, the group is entering a new phase of expansion, with plans to:
- Scale newly opened hospitals
- Increase bed capacity
- Enhance specialised medical services
The expansion strategy is expected to significantly increase patient capacity, enabling the group to serve a broader regional market as demand for quality healthcare rises across Asia.
Building a Regional Healthcare Leader
Beyond growth, the group’s ambition is to position itself among the leading healthcare institutions in the region.
Jeffrey Cheah articulated a long-term vision of developing Sunway Healthcare into a premier medical group in Asia, comparable to top global institutions, while contributing to Malaysia’s role as a regional healthcare hub.
This aligns with broader national aspirations to strengthen Malaysia’s healthcare ecosystem and attract international patients, particularly in high-value specialised treatments.
Healthcare as a Human-Centric Mission
Despite its expansion plans, the group reaffirmed that its core mission remains centred on patient care.
Sunway Healthcare aims to balance scale with quality, focusing not only on infrastructure and capacity, but also on delivering compassionate, patient-centric care.
As the group embarks on its next growth phase, its leadership stressed that healthcare remains fundamentally about improving lives, a principle that will continue to guide its strategy.
